Novel Agents to Enhance Tolerance to an Immunogen


Montana State University Technology Transfer, MT, US

I.P. Brief: 

A new approach to developing highly virulent, antigen-specific agents, called “tolerizing agents”, uses a mucosal targeting ligand fused to a specific antigen to induce host unresponsiveness solely to that antigen while avoiding global immune suppression.


Auto-immune Diseases, Inflammatory diseases, Allergies

Primary Industry: 

Biotech & Biological Sciences

Full IP Descriptions available on-site.